Investigation Launched on Undertakings, Private Healthcare Institutions and Undertakings Providing Technical and Operational Support to Private Healthcare Institutions Operating in the Türkiye Health Insurance Market
The Competition Board (Board) concluded the preliminary inquiry conducted to determine if the Act no 4054 on the Protection of Competition (Act no 4054) was violated by undertakings operating in the health insurance sector.
Within the scope of the preliminary inquiry, various allegations of infringement were examined, primarily including claims that insurance companies operating in the health insurance market might have engaged in conduct such as jointly determining, increasing, or maintaining premiums (prices) by reaching agreements among themselves; allocating customers, regions, or products; and exchanging sensitive information (price, cost, risk data), as well as claims that exclusionary agreements might have been concluded between insurance companies operating in the health insurance market and healthcare service providers.
In line with the information and documents obtained and the observations made during the preliminary inquiry, an investigation was launched on
– Allianz Sigorta Anonim Şirketi,
– Anadolu Anonim Türk Sigorta Şirketi,
– Ankara Anonim Türk Sigorta Şirketi,
– Aveon Global Sigorta Anonim Şirketi,
– Axa Sigorta Anonim Şirketi,
– Bupa Acıbadem Sigorta Anonim Şirketi,
– Hepiyi Sigorta Anonim Şirketi,
– Katılım Emeklilik ve Hayat Anonim Şirketi,
– Mapfre Sigorta Anonim Şirketi,
– Medisa Sigorta Anonim Şirketi,
– Prive Sigorta Anonim Şirketi,
– Zurich Sigorta Anonim Şirketi,
– Zurich Yaşam ve Emeklilik Anonim Şirketi,
– Quick Sigorta Anonim Şirketi,
– Acıbadem Sağlık Hizmetleri ve Ticaret Anonim Şirketi,
– Memorial Sağlık Yatırımları Anonim Şirketi,
– Özel Edremit Körfez Hastanesi,
– SenCard Partners Bilgi Teknolojileri Anonim Şirketi,
– Turassist Sağlık Destek Hizmetleri Anonim Şirketi,
in the Board meeting dated 16.03.2026, with an aim to determine if they violated the Act no 4054
